Cambrex to Present at the Deutsche Bank 41st Annual Health Care Conference
Get Alerts CBM Hot Sheet
Join SI Premium – FREE
EAST RUTHERFORD, N.J., April 27, 2016 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM) (“Cambrex”) is pleased to announce that Steven Klosk, President and Chief Executive Officer, will present at the Deutsche Bank 41st Annual Health Care Conference on May 4, 2016 at 2:50 p.m. EDT in Boston, MA.
The live audio webcast and slide presentation can be accessed from the Cambrex website at www.cambrex.com in the Investors section under “Webcasts & Presentations,” and a replay will be available for 90 days after the live event concludes.
About Cambrex
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. For more information, please visit www.cambrex.com.
Contact: Stephanie LaFiura Investor Relations Associate Phone: 201.804.3037 Email: [email protected]Source: Cambrex Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Invesco Ltd: Form 8.3 - Ageas SA/NV
- CANAL INSURANCE COMPANY APPOINTS PATRICK J. MULLEN TO BOARD OF DIRECTORS
- Atmus Filtration Technologies appoints Diego Donoso and Stuart A Taylor II to its Board of Directors
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Deutsche BankSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!